Potential New Revenue Stream: AbbVie’s BOTOX Cosmetic Application Progress and Market Implications
Exploring the implications of FDA's acceptance of BOTOX for masseter muscle prominence on AbbVie's financial outlook.
Spectral Medical (TSX: EDT) Announces Q2 2026 Results and FDA Progress: A Game Changer for Investors
Spectral Medical's Q2 2026 results and FDA advancements could redefine shareholder value and commercialization prospects.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
iRhythm's Strong Q2 Earnings and Vital Connect Acquisition: A Sign of Growth
iRhythm's Q2 earnings beat and acquisition of Vital Connect signal promising growth in wearable health tech.
Eli Lilly's Next-Gen Weight-Loss Drug Filing: A Game Changer for Investors
Eli Lilly's FDA filing for a new weight-loss drug could reshape the market landscape and challenge competitors like Novo…
Celsius Holdings Soars on Rockstar Energy Founder’s Stake Acquisition
Russ Savage's acquisition of a stake in Celsius Holdings sparks speculation and market movement.
NRx Pharmaceuticals Moves Closer to Launching Preservative-Free Ketamine
NRx Pharmaceuticals' ANDA for preservative-free ketamine passes FDA first-cycle review, signaling significant market pot…
Moderna's mRNA Flu Vaccine Approval: A Milestone with Market Implications
Moderna's recent FDA approval for its mRNA flu vaccine marks a significant step, yet market sentiment remains cautious.
Critical Minerals in Focus: Trump's Meeting with Mining CEOs and Its Market Implications
The Trump administration's focus on critical minerals highlights opportunities for investors in Lomiko Metals and Canadi…
US Jobs Report Shock: What the -23K Non-Farm Payrolls Mean for Markets
The unexpected -23,000 non-farm payrolls in July raises questions about market stability and economic outlook.
Harrow's Strategic Acquisition of TYRVAYA: A Game-Changer for Ophthalmic Treatments
Harrow's acquisition of TYRVAYA positions it as a key player in ophthalmic treatments, offering potential revenue growth…
Tarsus Pharmaceuticals Expands Eye Care Pipeline with Alkeus Acquisition
Tarsus Pharmaceuticals strengthens its eye care portfolio by acquiring Alkeus Pharmaceuticals, focusing on gildeuretinol…